Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2010
Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boostMichael Pinkawa, Richard Holy, Marc D Piroth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 4, 2011
Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancerMichael Pinkawa, Nuria Escobar Corral, Mariana Caffaro, et al.
Radiation Oncology (London, England)|November 26, 2009
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparisonMarc D Piroth, Michael Pinkawa, Richard Holy, et al.
Physics in Medicine and Biology|September 1, 2009
The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastomaFrank Thiele, Julia Ehmer, Marc D Piroth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2011
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapyMarc D Piroth, Richard Holy, Michael Pinkawa, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiformeMarc D Piroth, Michael Pinkawa, Richard Holy, et al.
Radiation Oncology (London, England)|June 26, 2016
Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volumeMarc D Piroth, Norbert Galldiks, Michael Pinkawa, et al.
Neoplasia (New York, N.Y.)|April 16, 2014
Cetuximab induces eme1-mediated DNA repair: a novel mechanism for cetuximab resistanceAgnieszka Weinandy, Marc D Piroth, Anand Goswami, et al.
Pageof 7